Evidence map›Paper›PMID 40250865›Full record

Observational studyStroke and vascular neurology2025

Effect of intravenous alteplase before endovascular therapy for atherothrombotic stroke-related large vessel occlusion: subanalysis of the RESCUE AT-LVO registry.

Hirotaka Hayashi, Satoshi Namitome, Seigo Shindo, Shinichi Yoshimura, Manabu Shirakawa, Mikiya Beppu, Nobuyuki Sakai, Hiroshi Yamagami, Kazutaka Uchida, Kazunori Toyoda and 18 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Stroke and vascular neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Hirotaka HayashiDepartment of Neurology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Kumamoto, Japan.
Satoshi NamitomeDepartment of Neurology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Kumamoto, Japan.
Seigo ShindoDepartment of Neurology, Kumamoto University, Kumamoto, Kumamoto Prefecture, Japan seigoshindou@gmail.com.ORCID 0000-0003-3876-2759
Shinichi YoshimuraDepartment of Neurosurgery, Hyogo Medical University, Nishinomiya, Hyogo Prefecture, Japan.
Manabu ShirakawaDepartment of Neurosurgery, Hyogo Medical University, Nishinomiya, Hyogo Prefecture, Japan.ORCID 0000-0001-5833-2217
Mikiya BeppuDepartment of Neurosurgery, Hyogo Medical University, Nishinomiya, Hyogo Prefecture, Japan.
Nobuyuki SakaiDepartment of Neurosurgery, Seijinkai Shizunai Hospital, Hidaka District, Hokkaido Prefecture, Japan.
Hiroshi YamagamiDivision of Stroke and Treatment, institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki Prefecture, Japan.ORCID 0000-0001-8133-3314
Kazutaka UchidaDepartment of Neurosurgery, Hyogo Medical University, Nishinomiya, Hyogo Prefecture, Japan.ORCID 0000-0003-4780-9598
Kazunori ToyodaDepartment of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka Prefecture, Japan.
Yuji MatsumaruDepartment of Neurology, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Yasushi MatsumotoDivision of Department and Discovery of Intervention Therapy, Tohoku University, Sendai, Miyagi Prefecture, Japan.
Kenichi TodoDepartment of Neurology, Tokyo Women's Medical University, Shinjuku, Tokyo, Japan.
Mikito HayakawaDepartment of Neurology, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Shinzo OtaDepartment of Neurosurgery, Ota Memorial Hospital, Ota, Gunma Prefecture, Japan.
Masafumi MorimotoDepartment of Neurosurgery, Yokohama Shintoshi Neurosurgical Hospital, Yokohama, Kanagawa Prefecture, Japan.
Masataka TakeuchiDepartment of Neurosurgery, Seisho Hospital, Odawara, Kanagawa Prefecture, Japan.
Hirotoshi ImamuraDepartment of Neurosurgery, National Cerebral and Cardiovascular Center, Suita, Osaka Prefecture, Japan.ORCID 0000-0001-8923-7861
Hiroyuki IkedaDepartment of Neurosurgery, Kurashiki Central Hospital, Kurashiki, Okayama Prefecture, Japan.ORCID 0000-0001-5710-7456
Kanta TanakaStroke Center, Kindai University Hospital, Osakasayama, Osaka Prefecture, Japan.
Hideyuki IshiharaDepartment of Neurosurgery, Yamaguchi University School of Medicine, Ube, Japan.
Hiroto KakitaDepartment of Neurosurgery, Iryo Hojin Seijinkai Shimizu Byoin, Kyoto, Kyoto Prefecture, Japan.
Takanori SanoDeapartment of Neurosurgery, Ise Red Cross Hospital, Ise, Mie Prefecture, Japan.
Hayato ArakiDepartment of Neurosurgery, Araki Neurosurgical Hospital, Hiroshima, Japan.
Tatsufumi NomuraDepartment of Neurosurgery, Okawara Neurosurgical Hospital, Muroran, Hokkaido Prefecture, Japan.
Fumihiro SakakibaraDepartment of Neurosurgery, Hyogo Medical University, Nishinomiya, Hyogo Prefecture, Japan.
Mitsuharu UedaDepartment of Neurology, Kumamoto University, Kumamoto, Kumamoto Prefecture, Japan.
Makoto NakajimaDepartment of Neurology, Kumamoto University, Kumamoto, Kumamoto Prefecture, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhether intravenous thrombolysis (IVT) should be administered prior to endovascular therapy (EVT) in patients with atherothrombotic stroke-related large vessel occlusion (AT-LVO) remains unclear. This study aimed to assess the efficacy and safety of IVT administered before EVT in this patient population.

methodsWe analysed the data from a multicentre registry of patients who underwent EVT for AT-LVO. Patients were categorised based on presumed mechanism of occlusion: in situ occlusion (intracranial group) or embolism from cervical artery occlusion/stenosis (tandem group). We compared the efficacy and safety of IVT before EVT in patients who received IVT (IVT stratum) and those who did not (non-IVT stratum). The primary outcome was a modified Rankin Scale score of 0-2 at 90 days.

resultsAmong the 336 patients in the intracranial group, 99 patients underwent IVT. The rate of favourable functional outcomes did not differ between IVT and non-IVT strata (51.1% vs 47.6%; adjusted ORs (aORs) (95% CI), 1.18 (0.66 to 2.09)); whereas any intracranial haemorrhage (ICH) (10.1% vs 3.8%; aOR, 2.98 (1.01 to 9.26)) and mortality at 90 days (6.4% vs 1.3%; aOR, 4.66 (1.02 to 26.73)) were significantly higher in the IVT stratum. Among the 233 patients in the tandem group, 88 patients underwent IVT, with no significant differences in efficacy or safety outcomes between the strata.

conclusionIn patients with AT-LVO, IVT before EVT did not improve outcomes and was associated with increased risk of ICH and mortality in those with in situ intracranial occlusion. IVT before EVT may not be recommended in patients with atherosclerotic intracranial occlusions.

Indexed as

Endovascular ProceduresFibrinolytic AgentsIschemic StrokeThrombolytic TherapyThrombotic StrokeTissue Plasminogen ActivatorAdministration, IntravenousAgedAged, 80 and overDisability EvaluationFemaleFunctional StatusHumansMaleMiddle AgedRecovery of FunctionFibrinolytic AgentsTissue Plasminogen ActivatorAtherosclerosisCerebral InfarctionInterventionIschemic StrokeThrombectomy

Identifiers

PMID40250865
PMCPMC12772968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.